Kazia Therapeutics Ltd Stock Australian S.E.
Equities
NRT
AU0000NRTDA2
Biotechnology & Medical Research
Sales 2022 | 10K 6.65K | Sales 2023 | 555 369.19 | Capitalization | 39.72M 26.42M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.96M | Net income 2023 | -20M -13.3M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.9M | Net cash position 2023 | 3.44M 2.29M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics Ltd
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |